MEDICINES CO /DE Financial Statements (2025 and earlier)
Company Profile
| Business Address |
8 SYLVAN WAY PARSIPPANY, NJ 07054 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2019 MRQ | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 240,937 | 151,359 | 541,835 | 373,173 | 370,741 | 376,727 | |||
| Cash and cash equivalents | 238,310 | 151,359 | 541,835 | 373,173 | 370,741 | 376,727 | |||
| Short-term investments | 2,627 | ||||||||
| Receivables | 3,496 | 22,087 | 52,328 | 155,691 | 101,585 | ||||
| Inventory, net of allowances, customer advances and progress billings | 864 | 5,559 | 70,898 | 64,584 | 81,450 | 87,105 | |||
| Inventory | 864 | 5,559 | 70,898 | 64,584 | 81,450 | 87,105 | |||
| Disposal group, including discontinued operation | 391,202 | 322,837 | |||||||
| Deferred tax assets | ✕ | 33,100 | 13,500 | ||||||
| Other undisclosed current assets | 53,002 | 11,688 | 19,133 | 19,995 | 15,992 | 12,524 | |||
| Total current assets: | 294,803 | 563,304 | 653,953 | 832,917 | 656,974 | 591,441 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 8,872 | 17,254 | 30,961 | 34,780 | 40,060 | 39,268 | |||
| Intangible assets, net (including goodwill) | 200,571 | 200,571 | 870,850 | 925,661 | 1,179,191 | 1,093,967 | |||
| Goodwill | 200,571 | 200,571 | 255,629 | 289,441 | 286,532 | 257,694 | |||
| Intangible assets, net (excluding goodwill) | 615,221 | 636,220 | 892,659 | 836,273 | |||||
| Restricted cash and investments | 6,710 | 5,541 | 5,032 | 1,428 | 1,446 | 1,574 | |||
| Other noncurrent assets | 4,924 | 5,613 | 715 | 12,165 | 8,034 | 15,032 | |||
| Deferred tax assets, net | ✕ | (164,500) | (128,700) | ||||||
| Other undisclosed noncurrent assets | 325,806 | 80,700 | 143,700 | 164,500 | 128,700 | ||||
| Total noncurrent assets: | 546,883 | 309,679 | 1,051,258 | 974,034 | 1,228,731 | 1,149,841 | |||
| TOTAL ASSETS: | 841,686 | 872,983 | 1,705,211 | 1,806,951 | 1,885,705 | 1,741,282 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 58,411 | 105,441 | 116,974 | 164,596 | 223,358 | 204,693 | |||
| Interest and dividends payable | 315 | ||||||||
| Employee-related liabilities | 43,992 | 35,492 | |||||||
| Accounts payable | 695 | 10,244 | 28,450 | 36,038 | 19,799 | 26,911 | |||
| Accrued liabilities | 57,716 | 95,197 | 88,524 | 128,558 | 159,252 | 142,290 | |||
| Debt | 53,749 | 257,911 | |||||||
| Disposal group, including discontinued operation | 60,580 | 67,515 | |||||||
| Business combination, contingent consideration, liability | 4,995 | 55,000 | 26,800 | 210,422 | ✕ | ||||
| Deferred revenue and credits | ✕ | ✕ | 4,476 | 18,902 | 19,863 | 14,350 | 5,052 | ||
| Other undisclosed current liabilities | (44,307) | (35,492) | |||||||
| Total current liabilities: | 58,411 | 175,492 | 244,625 | 536,685 | 403,823 | 174,253 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 12,787 | 8,724 | 101,697 | 103,342 | 174,403 | 136,417 | |||
| Deferred tax liabilities, net | ✕ | 89,992 | 89,996 | 164,459 | 128,677 | ||||
| Other liabilities | 12,787 | 8,724 | 11,705 | 13,346 | 9,944 | 7,740 | |||
| Other undisclosed noncurrent liabilities | 792,752 | 663,853 | 705,873 | 418,061 | 387,388 | 538,451 | |||
| Total noncurrent liabilities: | 805,539 | 672,577 | 807,570 | 521,403 | 561,791 | 674,868 | |||
| Total liabilities: | 863,950 | 848,069 | 1,052,195 | 1,058,088 | 965,614 | 849,121 | |||
| Temporary equity, carrying amount | 1,033 | 17,089 | |||||||
| Equity | |||||||||
| Equity, attributable to parent | (22,264) | 24,914 | 652,501 | 732,238 | 920,565 | 892,497 | |||
| Common stock | 77 | 76 | 73 | 72 | 68 | 66 | |||
| Treasury stock, value | (90,016) | (90,016) | (50,000) | (50,000) | (50,000) | (50,000) | |||
| Additional paid in capital | 1,452,975 | 1,377,393 | 1,256,890 | 1,208,058 | 1,045,078 | 991,982 | |||
| Accumulated other comprehensive income (loss) | (4,576) | (5,183) | (5,479) | 3,973 | 2,528 | (4,652) | |||
| Accumulated deficit | (1,380,724) | (1,257,356) | (548,983) | (429,865) | (77,109) | (44,899) | |||
| Equity, attributable to noncontrolling interest | (518) | (464) | (474) | (336) | |||||
| Total equity: | (22,264) | 24,914 | 651,983 | 731,774 | 920,091 | 892,161 | |||
| TOTAL LIABILITIES AND EQUITY: | 841,686 | 872,983 | 1,705,211 | 1,806,951 | 1,885,705 | 1,741,282 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 6,138 | 44,789 | 167,835 | 309,007 | 1,300 | 5,100 | ||
| Revenue, net | ✕ | ✕ | 44,789 | 167,835 | 309,007 | 724,408 | 687,864 | |
| Cost of revenue | (35,837) | (47,193) | (333,327) | (119,931) | (287,630) | (262,785) | ||
| Cost of goods and services sold | (7,255) | (47,193) | (71,347) | (119,931) | (287,630) | (262,785) | ||
| Gross profit: | (29,699) | (2,404) | (165,492) | 189,076 | (286,330) | (257,685) | ||
| Operating expenses | (161,712) | (662,692) | (196,433) | (461,549) | (537,151) | (447,964) | ||
| Other undisclosed operating income | 758,914 | 718,840 | ||||||
| Operating income (loss): | (191,411) | (665,096) | (361,925) | (272,473) | (64,567) | 13,191 | ||
| Nonoperating income (expense) | (46,301) | 1,840 | 327 | 400 | (6,345) | 1,368 | ||
| Investment income, nonoperating | (51,881) | (7,500) | (209) | |||||
| Other nonoperating income | 5,580 | 1,840 | 327 | 400 | 322 | 1,577 | ||
| Interest and debt expense | (49,411) | (48,564) | (49,843) | (37,092) | (15,701) | (15,531) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 47,428 | 17,592 | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (287,123) | (711,820) | (411,441) | (309,165) | (39,185) | 16,620 | ||
| Loss from equity method investments | (144) | (1,711) | (1,125) | |||||
| Other undisclosed income from continuing operations before income taxes | 1,019 | 7,549 | 292,155 | 57,646 | ||||
| Income (loss) from continuing operations before income taxes: | (286,104) | (704,271) | (119,286) | (251,663) | (40,896) | 15,495 | ||
| Income tax expense (benefit) | 50,888 | 96,576 | (70) | 29,743 | 6,837 | (1,360) | ||
| Other undisclosed income (loss) from continuing operations | (4,989) | 2,737 | ||||||
| Income (loss) from continuing operations: | (235,216) | (607,695) | (119,356) | (221,920) | (39,048) | 16,872 | ||
| Income (loss) before gain (loss) on sale of properties: | (235,216) | (708,373) | (119,172) | (221,920) | (39,048) | 16,872 | ||
| Income (loss) from discontinued operations | (100,678) | 184 | ||||||
| Other undisclosed net income (loss) | 112,060 | (130,826) | 6,838 | (1,360) | ||||
| Net income (loss): | (123,156) | (708,373) | (119,172) | (352,746) | (32,210) | 15,512 | ||
| Net income attributable to noncontrolling interest | 54 | 138 | 252 | |||||
| Other undisclosed net loss attributable to parent | (10) | (276) | (504) | |||||
| Net income (loss) available to common stockholders, diluted: | (123,156) | (708,373) | (119,118) | (352,756) | (32,348) | 15,260 | ||
Comprehensive Income ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (123,156) | (708,373) | (119,172) | (352,746) | (32,210) | 15,512 | ||
| Other comprehensive income (loss) | 607 | 296 | (9,452) | 1,445 | 7,180 | (3,886) | ||
| Comprehensive income (loss): | (122,549) | (708,077) | (128,624) | (351,301) | (25,030) | 11,626 | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 54 | (10) | 138 | (252) | ||||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (276) | |||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (122,549) | (708,077) | (128,570) | (351,311) | (25,168) | 11,374 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.